They also discovered that both gene and protein expression levels of Gal-3 were significantly higher in the hBM-MSCs-conditioned AML cell line than in the unconditioned one, indicating that hBM-MSCs induce Gal-3 overexpression in AML cells. This evidence concerns the gene LGALS3 and acute myeloid leukemia.